LT3743064T - Proteinurijos gydymas - Google Patents

Proteinurijos gydymas

Info

Publication number
LT3743064T
LT3743064T LTEPPCT/EP2019/066578T LTEP2019066578T LT3743064T LT 3743064 T LT3743064 T LT 3743064T LT EP2019066578 T LTEP2019066578 T LT EP2019066578T LT 3743064 T LT3743064 T LT 3743064T
Authority
LT
Lithuania
Prior art keywords
proteinuria
treatment
Prior art date
Application number
LTEPPCT/EP2019/066578T
Other languages
English (en)
Inventor
Thomas Engelbrecht Nordkild Jonassen
Original Assignee
Synact Pharma Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synact Pharma Aps filed Critical Synact Pharma Aps
Publication of LT3743064T publication Critical patent/LT3743064T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/402—1-aryl substituted, e.g. piretanide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LTEPPCT/EP2019/066578T 2018-06-22 2019-06-24 Proteinurijos gydymas LT3743064T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18179319 2018-06-22
PCT/EP2019/066578 WO2019243625A1 (en) 2018-06-22 2019-06-24 Treatment of proteinuria

Publications (1)

Publication Number Publication Date
LT3743064T true LT3743064T (lt) 2021-11-25

Family

ID=62750852

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/EP2019/066578T LT3743064T (lt) 2018-06-22 2019-06-24 Proteinurijos gydymas

Country Status (21)

Country Link
US (1) US20210121418A1 (lt)
EP (2) EP3970717A1 (lt)
JP (1) JP7124130B2 (lt)
KR (1) KR102494613B1 (lt)
CN (1) CN112292125B (lt)
AU (1) AU2019289563A1 (lt)
BR (1) BR112020024284A2 (lt)
CA (1) CA3102466A1 (lt)
CY (1) CY1124688T1 (lt)
DK (1) DK3743064T3 (lt)
ES (1) ES2899200T3 (lt)
HU (1) HUE056300T2 (lt)
IL (1) IL279497A (lt)
LT (1) LT3743064T (lt)
MX (1) MX2020012934A (lt)
PL (1) PL3743064T3 (lt)
PT (1) PT3743064T (lt)
SG (1) SG11202011614WA (lt)
SI (1) SI3743064T1 (lt)
WO (1) WO2019243625A1 (lt)
ZA (1) ZA202006987B (lt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4126232A1 (en) * 2020-03-31 2023-02-08 SynAct Pharma ApS Treatment of symptomatic viral diseases
IL309102A (en) * 2021-06-21 2024-02-01 Synact Pharma Aps Salts and formulations of phenyl pyrrole aminoguanidine
WO2023218048A1 (en) * 2022-05-12 2023-11-16 Synact Pharma Aps Resomelagon and its derivatives for the treatment of cardiovascular disease, hypertension and atherosclerosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004010172T2 (de) * 2003-11-18 2008-09-11 Solvay Pharmaceuticals Gmbh Pharmazeutische zusammensetzungen zur behandlung von nierenfunktionsstörungen
AU2007255366B2 (en) 2006-06-09 2013-07-18 Synact Pharma Aps Phenyl pyrrole aminoguanidine derivatives
CN105229024A (zh) * 2013-03-15 2016-01-06 Uab研究基金会 肾病综合征及相关病状的治疗方法

Also Published As

Publication number Publication date
BR112020024284A2 (pt) 2021-02-23
CY1124688T1 (el) 2022-07-22
MX2020012934A (es) 2021-03-25
HUE056300T2 (hu) 2022-02-28
US20210121418A1 (en) 2021-04-29
KR102494613B1 (ko) 2023-02-06
KR20210023829A (ko) 2021-03-04
WO2019243625A1 (en) 2019-12-26
EP3743064A1 (en) 2020-12-02
EP3970717A1 (en) 2022-03-23
EP3743064B1 (en) 2021-08-11
CN112292125B (zh) 2023-10-31
ES2899200T3 (es) 2022-03-10
DK3743064T3 (da) 2021-11-08
JP2021528395A (ja) 2021-10-21
CA3102466A1 (en) 2019-12-26
AU2019289563A1 (en) 2021-02-04
PT3743064T (pt) 2021-11-09
SI3743064T1 (sl) 2021-12-31
SG11202011614WA (en) 2021-01-28
JP7124130B2 (ja) 2022-08-23
ZA202006987B (en) 2022-03-30
PL3743064T3 (pl) 2022-01-10
CN112292125A (zh) 2021-01-29
IL279497A (en) 2021-01-31

Similar Documents

Publication Publication Date Title
ZA202006746B (en) Methods of treatment
GB201804514D0 (en) Treatment of pyroptosis
IL279497A (en) Treatment of protein in the urine
EP3684342C0 (en) TREATMENT PROCEDURES
GB2576572B (en) Processing of temporary-register-using instruction
GB201706406D0 (en) Method of treatment
IL270781A (en) Treatment of depressive disorders
EP3894768C0 (en) METHOD FOR CRYOHARDENING
GB201804515D0 (en) Treatment of necroptosis
GB201815588D0 (en) Method of treatment
PL3448340T3 (pl) Pomocniczy element aplikacyjny do opatrywania ran
GB201916428D0 (en) Treatment of hydro-carbon-contaminated materials
GB201603546D0 (en) Treatment of urine
SG11202105877YA (en) Method of treatment
SG11202105136WA (en) Application of chidamide
GB201907305D0 (en) Treatment of conditions
SG11202005850VA (en) Methods of treatment of hypertrigl yceridemia
IL290983A (en) Treatment methods
GB201918853D0 (en) Methods of treatment
GB201801249D0 (en) Methods of treatment
GB201900942D0 (en) Methods of treatment
GB201917253D0 (en) Treatment of conditions
GB201820236D0 (en) Method of treatment
GB201820157D0 (en) Method of treatment
PT3781172T (pt) Tratamento da pneumonia